Mv. Palmer et al., SAFETY AND IMMUNOGENICITY OF BRUCELLA-ABORTUS STRAIN RB51 VACCINE IN PREGNANT CATTLE, American journal of veterinary research, 58(5), 1997, pp. 472-477
Objective-To determine the safety and immunogenicity of Brucella abort
us strain RB51 as a vaccine in pregnant cattle. Animals-12 Polled Here
ford heifers obtained from a brucellosis-free herd and bred on site at
16 months of age to a brucellosis-free bull. Procedure-Pregnant heife
rs were vaccinated at 6 months' gestation with 10(9) colony-forming un
its of B abortus strain RB51 (n = 5), 3 x 10(8) colony-forming units o
f B abortus strain 19 (n = 5), or sterile pyrogen-free saline solution
(n = 2). Samples were periodically collected for serologic testing an
d lymphocyte blastogenesis assays. At full gestation, heifers were eut
hanatized and specimens were collected for bacteriologic culture, hist
ologic analysis, and lymphocyte blastogenesis assay, using various ant
igenic stimuli. Results-None of the strain RB51- or strain 19-vaccinat
es aborted or had gross or microscopic lesions at necropsy that were c
onsistent with brucellosis. Maternal blood mononuclear cells from stra
in RB51- and strain 19-vaccinates had proliferative responses to gamma
-irradiated strain RB51 and strain 19 that were greater than responses
by cells from nonvaccinated controls. In contrast, maternal superfici
al cervical lymph node cells from strain 19-vaccinates had proliferati
ve responses to gamma-irradiated strain RB51 or strain 19 bacteria gre
ater than those of cells from RB51-vaccinates and nonvaccinated contro
ls. None of the heifers vaccinated with strain RB51 developed antibodi
es detected by use of the standard tube agglutination test, but all de
veloped antibodies to strain RB51 that reacted in a dot ELISA, using i
rradiated strain RB51 as antigen. Conclusions-Pregnant cattle can be s
afely vaccinated with strain RB51 without subsequent abortion or place
ntitis. Furthermore, strain RB51 is immunogenic in pregnant cattle, re
sulting in humoral and cell-mediated immune responses, but does not in
terfere with serologic diagnosis of field infections.